Table 2.
Type of Studies | Tissue Molecular Mechanisms | Effects | References |
---|---|---|---|
In vivo (obese rats) | aortas: ↓ NOS signaling pathway | ↓ endothelial dysfunction and vascular insulin resistance | Akar et al. [126] |
In vivo (hypertensive rats) | rostral ventrolateral medulla (RVLM): ↑ AMPK activation | ↓ blood pressure and ROS generation ↑ ERK1/2–RSK–nNOS pathway |
Cheng et al. [127] |
In vivo (hypertensive rats) | endothelium: ↑ superoxide dismutase activity |
↓ oxidative stress induced by altered nitrite/nitrate levels ↓ development of hypertension |
Bhatt et al. [128] |
In vivo (obese rats) | liver: ↑ activation of SIRT1 signaling ↑ autophagy |
↓ endoplasmic reticulum stress ↓ hepatic lipid accumulation |
Ding et al. [129] |
In vitro and in vivo (obese rats) | Liver and hepatocytes treated with high concentration of glucose and insulin: ↑ AMPK activation |
↓ triacylglycerol (TG) accumulation ↑ improved insulin resistance |
Shang et al. [130] |
In vitro and in vivo (obese rats) | Liver: ↑ PKA/AMPK/PPARα signaling pathway activation |
↓ redox homeostasis and lipid accumulation | Huang et al. [131] |
In vitro and in vivo (NAFLD mice model) | Liver: ↑ AMPK/SIRT1/FAS/ SREBP1c signaling pathway activation |
↓ triglyceride accumulation ↑ improved insulin resistance |
Teng et al. [132] |
In vitro | 3T3 L1 adipocytes: ↑ SIRT1–AMPK signalling activation ↑ FOXO nuclear translocation |
↑ glucose metabolism ↑ improved insulin resistance |
Chen et al. [133] |
In vitro | Skeletal muscle cells: ↑ AMPK activation |
↑ GLUT4 translocation ↑ improved insulin resistance |
Vlavcheski et al. [134] |
In vitro and in vivo (obese mice) | Liver and hepatocytes: ↑ PI3K–Akt signalling activation |
↑ improved insulin resistance | Shu et al. [135] |
In vivo (obese mice) and human study (obese volunteers aged 30–55 years) | Adipose tissue: ↑ SIRT signalling activation | ↑ improved glycemic and lipid profiles ↑ expression of genes (UCP1, PRDM16, PGC1α) involved in adipose tissue thermogenesis |
Andrade et al. [136] |
In vivo (obese female mice) | Adipose tissue: ↑AMPK activation | ↑ brown-like adipocyte formation in inguinal white adipose tissue | Wang et al. [137] |
In vivo (obese mice) | Adipose tissue and gut: ↑ gut microbiota–bile acid–TGR5/UCP1 pathway |
↑ brown adipose tissue activation and white adipose tissue browning | Hui et al. [138] |
In vivo (obese mice) | Adipose tissue and gut: ↑ SIRT1 signalling activation |
↓ fat accumulation ↓ gut microbiota dysbiosis ↑ white adipose tissue browning |
Liao et al. [139] |
In vivo (obese mice) | Adipose tissue: ↑ antioxidative mitochondrial pathway | ↓ body weight gain ↓ oxidative and inflammatory condition ↓ gut microbiota alterations |
Campbell et al. [140] |
In vivo (atherosclerotic mice model) | ↓ enterohepatic farnesoid X receptor-fibroblast growth factor 15 axis | ↑ gut microbiota remodeling ↑ hepatic bile acid neosynthesis ↓ TMAO production |
Chen et al. [141] |